Novaquest Pharma Opportunities Fund Iii L P is a business in Raleigh, NC.
Business Name: | Novaquest Pharma Opportunities Fund Iii L P |
Categorized In: | |
Address: | 4208 Six Forks Road, Raleigh, NC 27609 |
Phone Number: | (919) 459-8620 |
NAICS Code: | 523120 |
SIC Code: | 6211 |
Business Type: | B2B (Business to Business) |
Founding Year: | 2013 |
Employee #: | 1 to 4 |
Location Type: | Single Location |
Annual Revenue ($): | $100.000 to $499.999 |
Share This Business: | |
Similar Businesses: |
Atlantic Capital Management LLC - Raleigh, NC 27609 Atlantic Capital Management - Raleigh, NC 27609 Pinnacle Capital Markets LLC - Raleigh, NC 27609 Wells Fargo Advisors LLC - Raleigh, NC 27609 Edward Jones - Raleigh, NC 27609 Pinnacle Capital Markets - Raleigh, NC 27609 Edward Jones - Raleigh, NC 27609 Edward Jones - Raleigh, NC 27609 Edward Jones - Raleigh, NC 27609 Raymond James - Raleigh, NC 27609 Edward D Jones & Co Limited Partnership - Raleigh, NC 27609 Waddell & Reed Inc - Raleigh, NC 27609 Brokersxpress of Raleigh - Raleigh, NC 27609 |
Novaquest Pharma Opportunities Fund Iii L P, a stable growing company under , is being run by . Since , their sales have been favorable and consistent at $100.000 to $499.999. Company location coordinates are: .
It can be reached by dialing (919) 459-8620, and you could get in touch with their sales team in 4208 Six Forks Road, Raleigh, North Carolina NC 27609. Visit their website at: to know more about the company’s history, products and services, as well as frequently asked questions and privacy policies.
Special deals are also offered from time to time. Their professional and honest business transactions fortifies both consumers and businesses in their B2B segments.
Their modest but solid single location houses 1 to 4 staff members. All are benefiting from the company’s generous programs and sound training solutions.
You can learn more by checking their classification codes: SIC – 6211 and NAIC – 523120. Call the hotline stated above for faster transaction and queries. Novaquest Pharma Opportunities Fund Iii L P would like to hear from you.